HOME › DRUGS › AUMOLERTINIB
ACTIVE SUBSTANCE / INN

AUMOLERTINIB

Brand name(s): Aumseqa
EMA LISTED
AUTHORISED
Carcinoma, Non-Small-Cell Lung
ACTIVE SUBSTANCE
Aumolertinib
REGULATORS
EMA
SPONSORS / MAH
SFL Pharmaceuticals Deutschland GmbH
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
AumseqaSFL Pharmaceuticals Deutschland GmbHAuthorised12/02/2026Carcinoma, Non-Small-Cell Lung

FULL INTELLIGENCE ON AUMOLERTINIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →